Does IPILIMUMAB Cause Autoimmune hepatitis? 352 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 352 reports of Autoimmune hepatitis have been filed in association with IPILIMUMAB (YERVOY). This represents 1.0% of all adverse event reports for IPILIMUMAB.
352
Reports of Autoimmune hepatitis with IPILIMUMAB
1.0%
of all IPILIMUMAB reports
73
Deaths
232
Hospitalizations
How Dangerous Is Autoimmune hepatitis From IPILIMUMAB?
Of the 352 reports, 73 (20.7%) resulted in death, 232 (65.9%) required hospitalization, and 57 (16.2%) were considered life-threatening.
Is Autoimmune hepatitis Listed in the Official Label?
Yes, Autoimmune hepatitis is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Autoimmune hepatitis?
NIVOLUMAB (481)
ATORVASTATIN (357)
PEMBROLIZUMAB (315)
ADALIMUMAB (237)
INFLIXIMAB (191)
ATEZOLIZUMAB (146)
METHOTREXATE (146)
NITROFURANTOIN (130)
PREDNISONE (107)
CARBOPLATIN (104)
Which IPILIMUMAB Alternatives Have Lower Autoimmune hepatitis Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN